205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.36%
Revenue growth exceeding 1.5x MRVL's 4.29%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
8.36%
Gross profit growth exceeding 1.5x MRVL's 3.82%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.36%
Other expenses change of 8.36% while MRVL maintains costs. Bruce Berkowitz would investigate efficiency.
8.36%
Operating expenses growth while MRVL reduces costs. John Neff would investigate differences.
8.36%
Total costs growth above 1.5x MRVL's 2.65%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-371.30%
EBITDA decline while MRVL shows 4.17% growth. Joel Greenblatt would examine position.
-350.37%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-371.30%
Operating income decline while MRVL shows 15.99% growth. Joel Greenblatt would examine position.
-350.37%
Operating margin decline while MRVL shows 5.31% growth. Joel Greenblatt would examine position.
371.30%
Other expenses growth while MRVL reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.50%
Net income growth while MRVL declines. John Neff would investigate advantages.
26.89%
Net margin growth while MRVL declines. John Neff would investigate advantages.
25.00%
EPS growth while MRVL declines. John Neff would investigate advantages.
25.00%
Diluted EPS growth while MRVL declines. John Neff would investigate advantages.
1.33%
Share count increase while MRVL reduces shares. John Neff would investigate differences.
1.33%
Diluted share reduction below 50% of MRVL's 1.17%. Michael Burry would check for concerns.